
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 19, 2025, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Macitentan Tablets, 10 mg".
Filed with NSE ·

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 19, 2025, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Macitentan Tablets, 10 mg".
6ix hasn’t read this filing yet.
Alembic Pharmaceuticals Limited on 6ix
Follow Alembic Pharmaceuticals into a list and get an email when it puts out news.
Follow Alembic Pharmaceuticals